3 R Health Care Products v. Cardinal Health 110

CourtAppellate Court of Illinois
DecidedMay 26, 2026
Docket1-24-1911
StatusPublished

This text of 3 R Health Care Products v. Cardinal Health 110 (3 R Health Care Products v. Cardinal Health 110) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
3 R Health Care Products v. Cardinal Health 110, (Ill. Ct. App. 2026).

Opinion

2026 IL App (1st) 241911

SECOND DIVISION May 26, 2026

No. 1-24-1911 ______________________________________________________________________________

IN THE APPELLATE COURT OF ILLINOIS FIRST JUDICIAL DISTRICT ______________________________________________________________________________

3 R HEALTH CARE PRODUCTS, INC., ) Appeal from the ) Circuit Court of Plaintiff-Appellant, ) Cook County ) v. ) 2024 L 1538 ) CARDINAL HEALTH 110, LLC, and ) THE DEPARTMENT OF CENTRAL ) Honorable MANAGEMENT SERVICES, ) Daniel J. Kubasiak, ) Judge Presiding Defendants-Appellees. ) _____________________________________________________________________________

JUSTICE ELLIS delivered the judgment of the court, with opinion. Presiding Justice Van Tine and Justice McBride concurred in the judgment and opinion.

OPINION

¶1 In 2021, Illinois sought bidders for a long-term commitment to supply various state

agencies with pharmaceutical goods. The bidding statute required that bidders subcontract a

certain amount of work to disadvantaged business enterprises, or “DBEs.” Plaintiff, 3R Health

Care Products, Inc. (“3R”), is a DBE that sought to be a subcontractor for the distributor

ultimately awarded the contract, defendant Cardinal Health 110, LLC (“Cardinal”). But 3R never

got that chance, as Cardinal obtained a full waiver of the contract’s DBE goal.

¶2 3R alleges the bidder obtained this DBE waiver by misrepresenting 3R’s capabilities to

the State. 3R also alleges it was the only DBE qualified to perform the work. Thus, absent those

misrepresentations, 3R alleges, Cardinal would have been obligated to include 3R in its bid. No. 1-24-1911

¶3 In 2024, after Cardinal was awarded the contract, 3R sued to recover for the portion of

the contract to which it was allegedly entitled. 3R sought, among other things, damages for

breach of contract and tortious interference with business expectancy, as well as a declaration

that Cardinal’s contract with the State was invalid.

¶4 The trial court dismissed the complaint, finding that 3R did not have standing to bring its

claims because the DBE “goal” was just that—a goal, not a legal obligation. So 3R had no

cognizable right to a subcontract or to a declaration that the contract was void, nor did 3R allege

a cognizable business expectancy.

¶5 We uphold the dismissal of the contract and declaratory-judgment counts, as 3R was not

a third-party beneficiary to the contract between Cardinal and the State and thus has no standing

to recover for a breach of that contract, to seek a rescission of that contract, or to obtain a

declaration that the contract is invalid.

¶6 But we reverse the dismissal of the tortious-interference claim. The allegations of the

complaint are sufficient, at the pleading stage, to allege that Cardinal intentionally sabotaged

3R’s statutory right to good-faith consideration as a DBE subcontractor. This right, plus the

allegation that plaintiff was the sole qualified subcontractor, is sufficient to plead an actionable

business expectancy. We remand for further proceedings.

¶7 BACKGROUND

¶8 As this case is at the pleading stage, we take the facts from the complaint and accept

them as true. Bosch v. NorthShore University Health System, 2019 IL App (1st) 190070, ¶ 5.

¶9 3R is an Illinois pharmaceutical distributor certified as a DBE under the Business

Enterprise for Minorities, Women, and Persons with Disabilities Act, 30 ILCS 575/0.01, et seq.

(West 2022), which we will call the “BEP Act.” (The complaint alleges that 3R’s principal

-2- No. 1-24-1911

owner and operator is Dr. Helen Randolph, is an African American woman.) Cardinal is a large

nationwide pharmaceutical distributor.

¶ 10 In June 2021, the Department of Central Management Services (CMS) issued a request

for proposal (RFP) seeking bids for a contract “to enable CMS, governmental units, and qualified

not-for-profit agencies to purchase drugs and pharmaceuticals on an as needed basis during the

contract period.” This June 2021 RFP contained an 8% DBE participation goal.

¶ 11 Under the BEP Act, to meet the DBE goal, bidders must either be a certified DBE

themselves or subcontract with a certified DBE. Id. § 2(A)(11). Or the bidder may obtain a

waiver of the DBE goal if the bidder demonstrates it made “good faith efforts” to secure DBE

participation but was unsuccessful. Id. § 7(3)(a). A bidder would not be considered to have made

good-faith efforts unless they contacted every registered DBE relevant to the RFP. A bidder’s

use of DBEs or attempt to solicit and request for waiver must be contained in a “utilization plan.”

Id. § 4(e).

¶ 12 That same month, June 2021, Cardinal contacted 3R to solicit 3R’s participation as a

certified DBE. After their meeting, Cardinal rejected 3R because it felt they were direct

competitors and “it would not benefit [Cardinal] to use [3R’s] services.” Cardinal then submitted

its bid and sought a waiver of the DBE goal. In August, CMS granted the waiver, and Cardinal

was awarded the contract. 3R claims the waiver was granted “based on [Cardinal’s]

misrepresentations in its DBE utilization plan.”

¶ 13 In September, 3R protested the award of the contract to Cardinal because it “did not make

good faith efforts to allow [3R’s] participation in the First Contract.” CMS overruled 3R’s

protest but nevertheless cancelled the first award “based on [3R’s] First Protest.”

-3- No. 1-24-1911

¶ 14 In October, CMS re-issued the RFP, which was identical except that the DBE

participation goal was raised from 8% to 9%. In November, Cardinal once again solicited 3R as a

potential DBE candidate. 3R reiterated its ability to fulfill the subcontract and submitted a

participation plan in November. 3R and Cardinal then met once again.

¶ 15 In that meeting, Cardinal expressed concern about “potential regulatory issues” in a

subcontract between the two. 3R attempted to dispel these concerns, explaining that it “was

already performing these duties” in a separate contract with the Department of Corrections, or

“IDOC.” Cardinal then asked only for the details of 3R’s IDOC contract, “rather than [3R’s]

ability to perform under the terms of the Second Contract—which [3R] was ready, willing, and

able to comply with.”

¶ 16 In December, Cardinal once again rejected 3R’s participation. While it was still

concerned that 3R was a competing distributor, it assured 3R that it was not the reason for

rejection this time around. Instead, Cardinal identified two concerns. First, because 3R was a

distributor, 3R would not be able to satisfy the one-day turnaround required by the RFP. That

turnaround was far tighter than the four-to-six-day delivery time in 3R’s IDOC contract. Second,

Cardinal claimed that 3R refused to provide a product list or price quote.

¶ 17 The complaint alleges that each reason was specious. The tighter turnaround under the

“Second Contract” was not a problem; just because its IDOC contract allowed for more time did

not mean that 3R could not perform a quicker turnaround. And Cardinal was focusing solely on

the products 3R delivered to IDOC; Cardinal “did not afford [3R] an opportunity to provide a list

of relevant products it could obtain pursuant to the requirements of the Second Contract.”

¶ 18 Cardinal once again sought a waiver of the RFP’s DBE goal. In the second utilization

Free access — add to your briefcase to read the full text and ask questions with AI

Related

XL Disposal Corp. v. John Sexton Contractors Co.
659 N.E.2d 1312 (Illinois Supreme Court, 1995)
Turner v. Memorial Medical Center
911 N.E.2d 369 (Illinois Supreme Court, 2009)
Anderson v. Vanden Dorpel
667 N.E.2d 1296 (Illinois Supreme Court, 1996)
Malatesta v. Leichter
542 N.E.2d 768 (Appellate Court of Illinois, 1989)
Haake v. TOWNSHIP HIGH SCHOOL GLENBARD
925 N.E.2d 297 (Appellate Court of Illinois, 2010)
Whitley v. Frazier
171 N.E.2d 644 (Illinois Supreme Court, 1961)
Voyles v. Sandia Mortgage Corp.
751 N.E.2d 1126 (Illinois Supreme Court, 2001)
Holmes v. Federal Insurance
820 N.E.2d 526 (Appellate Court of Illinois, 2004)
Western Nat. Bank of Cicero v. Moenning
586 N.E.2d 412 (Appellate Court of Illinois, 1991)
Advanced Concepts Chicago, Inc. v. CDW Corp.
938 N.E.2d 577 (Appellate Court of Illinois, 2010)
Antonacci v. Seyfarth Shaw, LLP
2015 IL App (1st) 142372 (Appellate Court of Illinois, 2015)
Patrick Engineering, Inc. v. The City of Naperville
2012 IL 113148 (Illinois Supreme Court, 2012)
Carlson v. The Rehabilitation Institute of Chicago
2016 IL App (1st) 143853 (Appellate Court of Illinois, 2016)
Horwitz v. Sonnenschein Nath & Rosenthal
2018 IL App (1st) 161909 (Appellate Court of Illinois, 2018)
Bosch v. NorthShore University Health System
2019 IL App (1st) 190070 (Appellate Court of Illinois, 2020)
Tillman v. Pritzker
2021 IL 126387 (Illinois Supreme Court, 2021)
Cahokia Unit School District No. 187 v. Pritzker
2021 IL 126212 (Illinois Supreme Court, 2021)
United States v. Triad Isotopes, Inc.
104 F. Supp. 3d 901 (N.D. Illinois, 2015)
Quiroz v. Chicago Transit Authority
2022 IL 127603 (Illinois Supreme Court, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
3 R Health Care Products v. Cardinal Health 110, Counsel Stack Legal Research, https://law.counselstack.com/opinion/3-r-health-care-products-v-cardinal-health-110-illappct-2026.